Condition
Non Small Cell Lung Cancer (Squamous or Non Squamous) clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Non Small Cell Lung Cancer (Squamous or Non Squamous) clinical trials that are recruiting, at sites in 12 countries (most in Australia (1), Austria (1), Belgium (1)). By phase: Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 12Countries
All recruiting trials (2)
-
EIK1001 with pembrolizumab and chemotherapy in stage 4 non-small cell lung cancer
This study tests whether adding EIK1001 to pembrolizumab plus standard chemotherapy can help people with stage 4 NSCLC.
-
Immunotherapy without chemotherapy for first-line advanced NSCLC with high PD-L1
This trial tests pembrolizumab or cemiplimab as first-line treatment for adults with advanced NSCLC and high PD-L1, to see if immunotherapy alone can be effective without chemotherapy.
Related topics
Quick answers
How many Non Small Cell Lung Cancer (Squamous or Non Squamous) clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 12 countries. The most sites are in Australia (1 trial), Austria (1 trial), Belgium (1 trial), Brazil (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.